AstraZeneca plc: PharmaVitae Profile
Assess the commercial impact of AstraZeneca's recent movement into the biologics market, spearheaded by its acquisition of MedImmune
 |
|---|
© companiesandmarkets.com
09.02.2010 19:55:43 AstraZeneca plc: PharmaVitae Profile - a new market research report on companiesandmarkets.com
(live-PR.com) - http://www.companiesandmarkets.com/Summary-Company-Profile/astrazeneca-plc-pharmavitae-profile-158272.asp
This analysis examines the historical and forecast performance for AstraZeneca in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
*Benchmark AstraZeneca´s performance against key rivals in
the prescription pharmaceutical sector
*Assess the commercial impact of AstraZeneca´s recent movement into the biologics market, spearheaded by its acquisition of MedImmune
*Analyse the exposure of AstraZeneca´s blockbuster portfolio to patent expiration and generic competition through to 2014
This analysis examines the historical and forecast performance for AstraZeneca in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
*Benchmark AstraZeneca´s performance against key rivals in
the prescription pharmaceutical sector
*Assess the commercial impact of AstraZeneca´s recent movement into the biologics market, spearheaded by its acquisition of MedImmune
*Analyse the exposure of AstraZeneca´s blockbuster portfolio to patent expiration and generic competition through to 2014
| Author: |
